Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
58,637,850
-
Share change
-
-1,654,166
-
Total reported value
-
$953,206,339
-
Put/Call ratio
-
87%
-
Price per share
-
$16.25
-
Number of holders
-
127
-
Value change
-
-$24,791,270
-
Number of buys
-
73
-
Number of sells
-
52
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2020
As of 30 Jun 2020,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,637,850 shares.
The largest 10 holders included
HealthCor Management, L.P., FMR LLC, NEA Management Company, LLC, Consonance Capital Management LP, Point72 Asset Management, L.P., Avidity Partners Management LP, PICTET ASSET MANAGEMENT LTD, BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, and Connor, Clark & Lunn Investment Management Ltd..
This page lists
127
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.